- Home
- IZEA vs DXR Comparison
IZEA vs DXR Comparison
Compare IZEA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IZEA | DXR |
|---|---|---|
| Founded | 2006 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 59.0M |
| IPO Year | 2010 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IZEA | DXR |
|---|---|---|
| Price | $2.48 | $10.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 33.0K | ★ 40.7K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $20,099,695.00 | $1,446,345.00 |
| Revenue This Year | $12.84 | $44,489.33 |
| Revenue Next Year | $20.57 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.38 | $8.56 |
| 52 Week High | $5.86 | $14.76 |
Technical Indicators
Market Signals| Indicator | IZEA | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 28.97 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $3.85 | N/A |
| Average True Range (ATR) | 0.12 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 23.64 | 0.00 |
Price Performance
Historical ComparisonAbout IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc is a full-service creator economy agency powered by proprietary ZED technology, with a mission to make Creator Economy solutions for marketers. It does this by lighting up the Creator Economy with IZEA's strategies, campaigns, and solutions that build brands and drive demand. Since launching the industry's first-ever influencer marketing platform in 2006, IZEA has facilitated nearly 4 million collaborations between brands and creators.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.